Come and discover our research activities and discuss with us about posters and demonstrations on December 13rd, 2023 from 1:30 pm to 5 pm, at the BDD building in Curie Institute, Paris.
After a brief introduction regarding the lab organization and how we work from 13:30 to 14:00 pm (which will be shown on a loop throughout the afternoon), our activities will be presented through posters and demonstrations arranged by theme. LITO members will be present to explain their work and projects and answers all questions you may have. Below is a preliminary list of the activities that will be displayed:
Positron Emission Tomography for in vivo molecular imaging:
1 - PET imaging for exploring cancer biology
2 - Gallium-68 oxine synthesis for the radiolabeling of extracellular vesicles and PET/CT imaging
Methodological developments:
3 and Demo - LIFEx: a free platform for radiomics and medical image analysis (poster and demo).
4 - Independent evaluation of an automatic segmentation method for FDG PET images
5 - RadShap: an original tool to help interpret radiomic models.
6 - ICARE: the method that won the MICCAI 2022 challenge to develop a model for predicting progression-free survival in Head and Neck cancer patients from PET/CT images.
Demo - ai4life: a validated method for automatic segmentation of tumor foci from whole-body PET/CT scans.
Breast cancer:
7 - Automatic segmentation of breast tumors from multimodal MRI to characterize response to neoadjuvant chemotherapy.
8 - Perturbation of the whole-body metabolic network in breast cancer patients.
Lung cancer:
9 - New prognostic and predictive Positron Emission Tomography (PET) biomarkers in patients with non-small cell lung cancer
10 - Prediction of response to tyrosine kinase inhibitors in patients with non-small cell lung cancer based on positron emission tomography (PET) images.
11 - Prediction of response to immunotherapy in patients with non-small cell lung cancer based on positron emission tomography (PET) images.
12 - Integration of multimodal data for predicting response to immunotherapy in patients with non-small cell lung cancer.
Lymphoma:
13 - New prognostic biomarkers from Positron Emission Tomography (PET) images in lymphoma patients.
Pediatric cancers:
14 - Prediction of genetic mutations in diffuse intrinsic pontine glioma using multi-modal MRI.
Imaging and radiotherapy:
15 - Predicting recurrence and location from MRI and PET images in Heand and Neck cancer patients who have undergone re-irradiation.
16 - A non-invasive method to study vocal fold function before and after irradiation of the laryngeal area.